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As more attention turns to when and howthe lives of terminally ill patients end inthe clinical setting, debate about the
issues of euthanasia and physician-assisted suicide
grows.1−5 Euthanasia has been discussed in Europe
and the United States for more than a century, and
the public has become more accepting of it.4−10
Announcing its first-ever ruling in favour of an
unconscious patient’s right to die with dignity, the
Korean Supreme Court recently ruled that doctors
of an elderly wo man in a persistent vegetative
state re move the artificial respirator from her on
the basis of her presumed wishes.11 A public
debate aimed at legalizing withdrawal of futile
life-sustaining treatment, exposure to stories of
dying pa tients in the mass media, and the court’s
decision may have led to a greater awareness of,
and sensibility toward, the rights of terminally ill
patients. In 2000, only 16.5% of 535 Korean
oncologists surveyed said that they would pre-
scribe morphine for severe cancer pain, and more
than half of 655 patients who had pain said they
had inadequate pain  management.12
Although much has been written about atti-
tudes toward how the general public would
choose to die in the clinical setting,4,13 most studies
have focused on only euthanasia and physician-
assisted sui cide.14−18 We conducted a large survey
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Background: Whereas most studies have fo -
cused on euthanasia and physician-assisted
suicide, few have dealt comprehensively with
other critical interventions administered at
the end of life. We surveyed cancer patients,
family caregivers, oncologists and members of
the general public to determine their atti-
tudes toward such interventions.
Methods: We administered a questionnaire to
four groups about their attitudes toward five
end-of-life interventions — withdrawal of
futile life-sustaining treatment, active pain
control, withholding of life-sustaining mea-
sures, active euthanasia and physician-assisted
suicide. We performed multivariable analyses
to compare attitudes and to identify socio -
demographic characteristics associated with
the attitudes.
Results: A total of 3840 individuals — 1242 can-
cer patients, 1289 family caregivers and 303
oncologists from 17 hospitals, as well as 1006
members of the general Korean population —
participated in the survey. A large ma jority in
each of the groups supported withdrawal of
futile life-sustaining treatment (87.1%–94.0%)
and use of active pain control (89.0%–98.4%).
A smaller majority (60.8%–76.0%) supported
withholding of life- sustaining treatment.
About 50% of those in the patient and general
population groups supported active euthanasia
or physician-assisted suicide, as compared with
less than 40% of the family caregivers and less
than 10% of the oncologists. Higher income
was significantly associated with approval of
the withdrawal of futile life-sustaining treat-
ment and the practice of active pain control.
Older age, male sex and having no religion
were significantly associated with approval of
withholding of life-sustaining measures. Older
age, male sex, having no religion and lower edu-
cation level were significantly associated with
approval of active euthanasia and physician-
assisted  suicide.
Interpretation: Although the various partici-
pant groups shared the same attitude toward
futile and ameliorative end-of-life care (the
withdrawal of futile life-sustaining treatment
and the use of active pain control), oncologists
had a more negative attitude than those in
the other groups toward the active ending of
life (euthanasia and physician-assisted  suicide).
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to examine attitudes among cancer pa tients, fam-
ily caregivers, oncologists and members of the
general public toward critical interventions at the
end of life of terminally ill patients.
Methods
Study population
In this multicentre study, we surveyed the fol-
lowing four groups from 2008 through 2009:
cancer patients, family caregivers, oncologists
and members of the general Korean population.
Patients
Oncologists at 17 hospitals (16 general hospitals
and Korea’s National Cancer Center) were asked
to identify cancer patients at outpatient clinics.
Patients were eligible to participate if they were
20 years or older and were able to fill out ques-
tionnaires, communicate with an interviewer,
understand the intent of the study and provide
informed consent. Of the 1378 consecutive pa -
tients identified, 132 were excluded: 27 had seri-
ous illness (e.g., dyspnea) or were incompetent,
21 had speech or hearing limitations, and 84
refused to participate because of time constraints
or because they thought participation would be an
inconvenience or would entail an invasion of pri-
vacy. Of the 1246 patients who were interviewed,
4 re turned incomplete questionnaires; the remain-
ing 1242 patients were included in our study (re -
sponse rate 90.1% of those considered eligible).
Family caregivers
For each patient included in the study, the relative
who provided the patient with the most assistance
was given information about the study and inter-
viewed by a trained research assistant. Those who
were not well enough to fill out a questionnaire,
communicate with an interviewer or understand
the study well enough to provide informed con-
sent were ineligible. Of the 1355 eligible family
caregivers, 58 were excluded because of speech or
hearing limitations or because they were not well
or did not sign a consent form. Of the remaining
1297 caregivers who were interviewed, 8 did not
complete the questionnaire; the remaining 1289
were included in our study (response rate 95.1%
of those considered eligible).
Oncologists
We obtained a list of 374 oncologists at the 17
hospitals from the Korean Cancer Association.
Seventy-one refused to participate (primarily
because of a busy schedule). Of the remaining
303 (81.0%), all completed the questionnaire.
General population
Our goal was to survey 1000 members of the gen-
eral Korean public who were 20–70 years of age,
distributed over the 17 city and local districts. At
each site, we constructed the sample in two strata
(by age and sex), according to the guidelines of
the 2005 Census of Korea. Starting with 1325 ran-
domly selected residential telephone numbers, we
obtained our final sample using a probability-
 proportional-to-size technique, which is a widely
recommended method for obtaining a representa-
tive national sample.19 The survey was conducted
by telephone by Korea Research Inc. using a
structured questionnaire and professional inter-
viewers. A total of 1006 people were interviewed
(response rate 75.9%).
Questionnaire
The questionnaire was based on those used in
previous studies of this issue.5,9,11,20,21 It was de -
signed to query participants about their attitudes
toward five end-of-life interventions — with-
drawal of futile life-sustaining treatment, active
pain control, withholding of life- sustaining mea-
sures, active euthanasia and physician-assisted
suicide (as defined in Box 1). Possible scores
ranged from 1 to 4 for each of the items (1 =
strongly agree, 2 = agree, 3 = disagree and 4 =
strongly disagree). To agree meant to approve of
the practice. The questionnaire was also designed
to collect demographic information (sex, age,
education level, employment status, religion and
income) and information on attitudes toward the
disclosure of terminal status, hospice palliative
care and advance directives. 
There was no coercion to participate in this
survey, but the patient’s physician, as a co -
researcher, recommended completion of the
questionnaire. No participants were paid, all
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Box 1: Definitions of terms used in questionnaire to determine 
attitudes toward critical interventions at the end of life of 
terminally ill patients 
Withdrawal of futile  
life-sustaining 
treatment 
The practice of allowing a patient at the end of life 
to die naturally by withdrawing life-sustaining 
treatment deemed medically futile without the 
primary intention of ending the patient’s life 
Active pain control The practice of using opioids to relieve pain 
Withholding of  
life-sustaining 
measures 
The practice of withholding from an unconscious 
patient (e.g., one in a vegetative state) drugs,  
life-support systems or other life-prolonging 
treatments with the primary intention of ending 
the patient’s life 
Active euthanasia The practice of injecting a patient with a lethal dose 
of a medication with the primary intention of 
ending the patient’s life 
Physician-assisted 
suicide 
The practice of providing a competent patient with 
a prescription for a medication that the patient can 
use with the primary intention of ending life 
(except for the general population) provided writ-
ten informed consent, and the institutional review
boards of the 17 hospitals approved the protocol.
Statistical analysis
We report sociodemographic variables as num-
bers and percentages. If the response to any
question was “strongly agree” or “agree,” the
participant was classified as approving the man-
ner of death in question. 
Answers were treated as dichotomous out-
comes, and we used a logistic regression model to
test associations of agreement with the socio -
demographic characteristics of the respondents.
We performed multivariable analyses as follows.
First, in the exploratory stage of variable selection
for the sociodemographic characteristics (age, sex,
education level, employment status, religion and
monthly income), we applied a forward (and
backward) stepwise procedure to fit a logistic
Research
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Table 1: Sociodemographic characteristics of 3840 people who participated in a survey about attitudes 
toward critical interventions at the end of life of terminally ill patients 
 Group; no. (%) 
Characteristic 
Cancer patients 
n = 1242 
Family caregivers 
n = 1289 
Oncologists 
n = 303 
General public 
n = 1006 
Sex n = 1242 n = 1289 n = 303 n = 1006 
Male 588 (47.3) 483 (37.5) 247 (81.5) 507 (50.4) 
Female 654 (52.7) 806 (62.5) 56 (18.5) 499 (49.6) 
Age, yr n = 1234 n = 1283 n = 300 n = 1006 
≤ 39 161 (13.0) 527 (41.1) 152 (50.7) 483 (48.0) 
40–49 355 (28.8) 330 (25.7) 89 (29.7) 249 (24.8) 
≥ 50 718 (58.2) 426 (33.2) 59 (19.7) 274 (27.2) 
Education n = 1227 n = 1286 n = 303 n = 1006 
Middle school or less 288 (23.5) 156 (12.1) 0  128 (12.7) 
High school 524 (42.7) 467 (36.3) 0  383 (38.1) 
College or higher 415 (33.8) 663 (51.6) 303 (100.0) 495 (49.2) 
Employed at time 
of diagnosis 
 
n = 1232 
 
n = 1284 
 
n = 303 
 
n = 1006 
Yes 524 (42.5) 686 (53.4) 303 (100.0) 470 (46.7) 
No 708 (57.5) 598 (46.6) 0  536 (53.3) 
Religion n = 1232 n = 1280 n = 302 n = 1006 
Christian 534 (43.3) 564 (44.1) 190 (62.9) 399 (39.7) 
Buddhist 297 (24.1) 316 (24.7) 21 (7.0) 209 (20.8) 
Other 41 (3.3) 35 (2.7) 0  22 (2.2) 
None 360 (29.2) 365 (28.5) 91 (30.1) 376 (37.4) 
Monthly income, 
in 1000 Korean won 
 
n = 1203 
 
n = 1268 
 
n = 303 
 
n = 914 
≤ 150  371 (30.8) 244 (19.2) 0  255 (27.9) 
151–300 459 (38.2) 507 (40.0) 0  352 (38.5) 
> 300 373 (31.0) 517 (40.8) 303 (100.0) 307 (33.6) 
Type or site of cancer n = 1233 n = 1273     
Breast 303 (24.6) 178 (14.0)     
Stomach 236 (19.1) 289 (22.7)     
Lung 111 (9.0) 172 (13.5)     
Colon 107 (8.7) 128 (10.1)     
Leukemia 96 (7.8) 76 (6.0)     
Cervical 59 (4.8) 40 (3.1)     
Liver 46 (3.7) 61 (4.8)     
Bladder 9 (0.7) 10 (0.8)     
Other 266 (21.6) 319 (25.1)     
regression model with an entry (and removal)
level of 0.15. We also included variables (age,
sex, education level, religion and monthly in -
come) that showed statistical significance at the
0.10 level in the univariable model. Finally, we
used hierarchical variable selection to select a sta-
tistical best-fit and clinically plausible model.
Because the four participant categories were
associated with sociodemographic variables, it
was not possible to estimate some parameters
when all variables were included in the logistic
regression model together. Hence, we present the
effect of the participants’ category sep arately in
a graph and table.
Results
Table 1 lists the sociodemographic characteris-
tics of the 1242 patients, 1289 family caregivers,
303 oncologists and 1006 members of the gen-
eral public who participated in the survey.
Table 2 shows the results of the univariable
and multivariable logistic regression analyses of
factors associated with approval of the five criti-
cal interventions studied. After adjustment for
possible confounders, we found that older age
and higher income were significantly associated
with approval of withdrawal of futile life-
 sustaining treatment. Higher income was the
only characteristic associated with approval of
active pain control. Older age, male sex and hav-
ing no religion were associated with approval of
withholding of life- sustaining measures. Older
age, male sex, having no religion and lower edu-
cation level were associated with approval of
active euthanasia and physician-assisted suicide.
Most of the participants in each of the four
study groups approved of the withdrawal of futile
Research
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Table 2: Factors associated with approval of critical interventions at the end of life of terminally ill patients* 
Characteristic† 










Age ≥ 50 (v. < 50) yr           
No. (%) 1323 (90.6) 1304 (89.4) 1120 (77.0) 790 (54.1) 709 (48.9) 
Crude OR (95% CI) 1.27 (1.02–1.57) 0.83 (0.67–1.03) 1.45 (1.24–1.68) 1.87 (1.64–2.13) 1.57 (1.38–1.80) 
Adjusted OR‡ (95%CI) 1.42 (1.12–1.80) – 1.46 (1.24–1.72) 1.53 (1.32–1.78) 1.36 (1.17–1.58) 
Male (v. female) sex           
No. (%) 1592 (88.7) 1652 (91.3) 1342 (74.4) 848 (46.9) 791 (43.9) 
Crude OR (95% CI) 0.91 (0.74–1.11) 1.22 (0.98–1.51) 1.19 (1.03–1.37) 1.20 (1.05–1.36) 1.16 (1.02–1.32) 
Adjusted OR‡ (95%CI) – – 1.25 (1.06–1.47) 1.42 (1.23–1.64) 1.31 (1.14–1.51) 
High school education  
or lower (v. college or beyond) 
        
No. (%) 1705 (89.1) 1701 (88.5) 1426 (74.4) 1009 (52.5) 928 (48.4) 
Crude OR (95% CI) 0.96 (0.78–1.18) 0.63 (0.51–0.79) 1.20 (1.04–1.39) 1.93 (1.70–2.20) 1.70 (1.49–1.94) 
Adjusted OR‡ (95%CI) – 0.82 (0.63–1.06) 1.08 (0.91–1.29) 1.41 (1.22–1.63) 1.28 (1.01–1.48) 
Employed (v. not employed) 
at diagnosis 
         
No. (%) 1461 (88.5) 1501 (89.9) 1244 (74.8) 795 (47.8) 744 (44.8) 
Crude OR (95% CI) 0.93 (0.75–1.15) 1.02 (0.82–1.28) 1.12 (0.96–1.30) 1.01 (0.88–1.15) 0.97 (0.85–1.11) 
Adjusted OR‡ (95%CI) – – – – – 
Having no religion 
(v. having a religion) 
          
No. (%) 1053 (89.8) 1080 (90.8) 885 (74.9) 558 (47.1) 576 (48.8) 
Crude OR (95% CI) 1.08 (0.86–1.35) 1.06 (0.84–1.35) 1.18 (1.01–1.39) 1.15 (1.01–1.32) 1.49 (1.30–1.72) 
Adjusted OR‡ (95%CI) – – 1.21 (1.02–1.44) 1.19 (1.02–1.32) 1.55 (1.30–1.72) 
Monthly income > 200  
(v. ≤ 200), in 1000 Korean won 
        
No. (%) 1840 (90.2) 1873 (91.0) 1520 (74.2) 929 (45.4) 903 (44.3) 
Crude OR (95% CI) 1.39 (1.12–1.73) 1.46 (1.17–1.82) 1.07 (0.92–1.25) 0.81 (0.70–0.93) 0.93 (0.81–1.07) 
Adjusted OR‡ (95%CI) 1.44 (1.15–1.81) 1.43 (1.14–1.79) – 0.98 (0.84–1.14) – 
Note: CI = confidence interval, OR = odds ratio. 
*Participants who responded “strongly agree” or “agree” to questions about the interventions studied were considered to approve of the interventions. 
†Answers about characteristics were dichotomized for this analysis. 
‡Adjusted for variables listed in this table. Adjusted ORs are presented only for variables with statistically significant crude ORs. 
life-sustaining treatment (87.1%–94.0%) and the
practice of active pain control (89.0%–98.4%)
despite the associated risk of life- shortening
effects (Figure 1, Table 3). A smaller majority
(60.8%–76.0%) approved of the withholding of
life-sustaining measures. About 50% of those in
the patient and general public groups supported
active euthanasia and physician-assisted suicide,
as compared with less than 40% of the family
caregivers and less than 10% of the oncologists.
Interpretation
In this survey of attitudes toward critical inter-
ventions at the end of life of terminally ill pa -
tients, the most interesting finding was that most
of the participants in each of the four study
groups — pa tients, family caregivers, oncolo-
gists and members of the general public —
showed a positive attitude toward the withdrawal
of futile life- sustaining treatment and the practice
of active pain control.
These findings suggest that recent debates
about death with dignity and a generalized desire
to counter “bad” ways of dying have influenced
opinion.4,22,23 In the absence of effective pallia-
tion, it is no surprise that patients and others
would choose a route that avoids the prolonga-
tion of suffering. Palliative care was introduced
to Korea recently but is still rare, and practical
services are provided mainly by oncologists or
family physicians in inpatient care units.
Overall, the attitudes of the group represent-
ing the general public were similar to those of
the cancer patients. This similarity might be
explained by the general public’s empathy for
patients with terminal illness. Whereas the
patients and the members of the general public
appeared to support patient autonomy and has-
tening of the dying process, the oncologists and
family caregivers who participated in the survey
had more negative attitudes. Their attitudes
might be influenced by uncertainty about the
prognosis, religious beliefs, fear of pressure on
vulnerable patients and legal circumstances.5
In Korea, where advance directives are not
legally binding, the withholding or withdrawal of
futile life-sustaining treatment according to a
patient’s wishes is controversial, and it is not dealt
with in medical training programs. In our study,
however, oncologists were the group that was
most accepting of the withdrawal of futile life-
 sustaining treatment and the practice of active pain
control. These findings suggest that oncologists
have an interest in improving end-of-life care, as is
supported by physicians working in voluntary hos-
pice services in the United  Kingdom.24
In our survey, attitudes toward acceptance of
euthanasia and physician-assisted suicide were
associated with age, sex and religious belief. In
most other studies, however, sex was not a major
influential factor,14,15,20,25 and the effect of age was
inconsistent.9,14,20 As people age, they are con-
fronted with deteriorating health and the death of
friends or family members; thus, they may be
expected to support the easing of dying through
withdrawal of life- sustaining treatment and physi-
cian-assisted suicide.5,9 These findings suggest that
the shift in attitudes comes from the experiences
of an aging population rather than from the
younger generation’s “new ideas.”
We found that religious belief correlated sig-
nificantly and negatively with acceptance of
interventions used for terminally ill patients at
the end-of-life. This observation supports pre -
vious findings that religion is a strong determi-
nant of the attitudes of patients,11,14,17,20,26 oncolo-
gists,9,11,17,27 family caregivers20,25 and the general
public.4,11,17 We found that participants with lower
education levels were more supportive of active
Research


































Figure 1: Proportion of respondents who approved of critical interventions at the end of life of terminally
ill patients, by participant group.
euthanasia and physician-assisted suicide than
were more educated participants. It is interesting
that religion and education correlated similarly
with attitude toward euthanasia. These findings
warrant further study for confirmation.
Although there has been concern in the United
States that poor people would be more likely than
those in higher income groups to choose a has-
tened death,21 we found no association between
monthly income and attitude to ward any of the
life-ending interventions studied. In Korea, there
are few uninsured people. National health insur-
ance, together with med icare for low-income
people, covers almost the whole population.
Especially for cancer, coverage is high, and the
patient’s out-of-pocket share was 10% in 2000
and decreased to 5% in 2010. That helps explain
the lack of an association be tween income and
support for physician- assisted suicide and eutha -
nasia.28 In contrast, higher income was associated
with approval of the withdrawal of futile life-
 sustaining treatment and the practice of active
pain control. These findings suggest that the asso-
ciation between income and end-of-life interven-
tions varies by type of  intervention.
Surveys conducted in other countries have
reported that 60%–90% of patients support eu -
thanasia or physician-assisted suicide,8,14−17,20 as
compared with only about 50% of patients in our
study. The relatively higher proportion of nega-
tive attitudes in Korea toward the hastening of
death of terminally ill patients could possibly be
ascribed to different cultural attitudes toward
personal autonomy. Earlier empirical studies,
especially those from Western countries, gener-
ally showed an increase in public acceptance of
euthanasia that might be explained by a rising
belief in personal autonomy regarding end-of-
life decisions and the individualism that has been
increasing over the last two decades.4 It is under-
standable, then, that euthanasia is more accept-
able in those parts of the world that traditionally
favour personal autonomy (e.g., North America
and Europe) and less acceptable in parts that
favour more paternalistic or family-centred mod-
els of decision-making (e.g., Asia).
Our finding that oncologists were more nega-
tive than the other study groups toward euthana-
sia and physician-assisted suicide supports find-
ings from the Netherlands, the United States15 and
the United Kingdom.26 Moreover, oncologists in
the United States and Europe are reluctant to
accede to requests of terminally ill patients to
help hasten death, probably because they will be
held accountable for the deaths.5,9,21 Other reasons
might be a belief that symptoms can be con-
trolled without resorting to euthanasia or, per-
haps, the honouring of the Hippocratic oath.
Limitations
Our study has several limitations. First, we en -
rolled only cancer patients, their family care-
givers and oncologists from university hospitals,
so our results may not be generalizable to other
treatment settings or to other terminal illnesses.
The nature of cancer is such, however, that most
patients are likely to face the end-of-life issues
discussed here.
Second, we interviewed the patients, family
caregivers and oncologists in person, whereas
the members of the general public were surveyed
by telephone. This difference may have lessened
the validity of the comparisons. However, we
used a model based on identical study designs
and questionnaires for all participating groups in
an attempt to overcome this shortcoming. 
Third, although there was no obligation to par-
ticipate in the survey, the response rates in the
patient and family caregiver groups were very
high. High response rates are not usual for sur-
veys in Korea; however, in our study, the pa -
tients’ oncologists recommended participation,
which may have caused the patients and their
family caregivers to feel a sense of obligation. It
may also have caused patients to provide answers
that the survey seemed to want. 
Fourth, although the questionnaire in our sur-
vey was designed on the basis of those used in
previous studies of this issue,5,9,11,20,21 it was not
validated separately. 
Fifth, we did not analyze the attitudes of pa -
tients by their stage of cancer. Those who knew
they were dying may have had different opinions
from those hopeful in the face of a new diagno-
sis. Further study is needed for confirmation. 
Finally, we did not include in the database
any important variables — such as the partici-
pants’ own experiences with chronic or critical
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Table 3: Proportion of respondents who approved of critical interventions 
at the end of life of terminally ill patients, by participant group* 






Withdrawal of futile  
life-sustaining treatment 
89.9 87.1 94.0 89.8 
Active pain control 89.7 90.4 98.4 89.0 
Withholding of  
life-sustaining measures 
76.0 70.3 60.8 74.9 
Active euthanasia 55.3 38.4   8.3 50.4 
Physician-assisted suicide 51.7 35.6   6.3 49.2 
*Participants who responded “strongly agree” or “agree” to questions about the 
interventions studied were considered to approve of the interventions. 
Research
diseases, their experiences of caring for family
members or loved ones, or their being cared for
by family members. Including those variables in
the multiple logistic regression analysis might
have changed the results.
Conclusion
Our study suggests that, although the various
participant groups shared the same attitude
toward futile and ameliorative end-of-life care
(the withdrawal of futile life-sustaining treatment
and the use of active pain control), oncologists
had a more negative attitude than those in the
other groups toward the active ending of life
(euthanasia and physician-assisted suicide).
References
1. Murray SA, Boyd K, Sheikh A. Palliative care in chronic illness.
BMJ 2005;330:611-2.
2. Quill TE. Dying and decision making — evolution of end-of-life
options. N Engl J Med 2004;350:2029-32.
3. Corn BW. Ending end-of-life phobia — a prescription for
enlightened health care reform. N Engl J Med 2009;361:e63.
4. Cohen J, Marcoux I, Bilsen J, et al. Trends in acceptance of
euthanasia among the general public in 12 European countries
(1981–1999). Eur J Public Health 2006;16:663-9.
5. Gielen J, Van Den Branden S, Broeckaert B. Attitudes of Euro-
pean physicians toward euthanasia and physician-assisted suicide:
a review of the recent literature. J Palliat Care 2008; 24: 173-84.
6. van der Maas PJ, Pijnenborg L, van Delden JJ. Changes in
Dutch opinions on active euthanasia, 1966 through 1991. JAMA
1995; 273:1411-4.
7. Benson JM. The polls-trends — end-of-life issues. Public Opin Q
1999;63:263-77.
8. Blendon RJ, Szalay US, Knox RA. Should physicians aid their
patients in dying? The public perspective. JAMA 1992; 267:
2658-62.
9. Meier DE, Emmons CA, Wallenstein S, et al. A national survey
of physician-assisted suicide and euthanasia in the United States.
N Engl J Med 1998;338:1193-201.
10. Blizzard R. Canadians and the ethics of euthanasia. Gallup; 2002
July 23. Available:  www.gallup.com/poll/6442/Canadians -Ethics
-Euthanasia.aspx (accessed 2011 May 19).
11. Myo-ja S. Top court upholds “die with dignity” right. JoongAng
Daily 2009; May 22.
12. Yun YH, Park SM, Lee K, et al. Predictors of prescription of
morphine for severe cancer pain by physicians in Korea. Ann
Oncol 2005;16:966-71.
13. van der Heide A, Onwuteaka-Philipsen BD, Rurup ML, et al.
End-of-life practices in the Netherlands under the Euthanasia
Act. N Engl J Med 2007;356:1957-65.
14. Suarez-Almazor ME, Newman C, Hanson J, et al. Attitudes of
terminally ill cancer patients about euthanasia and assisted sui-
cide: predominance of psychosocial determinants and beliefs
over symptom distress and subsequent survival. J Clin Oncol
2002;20:2134-41.
15. Wolfe J, Fairclough DL, Clarridge BR, et al. Stability of attitudes
regarding physician-assisted suicide and euthanasia among oncol-
ogy patients, physicians, and the general public. J Clin Oncol
1999; 17:1274.
16. Sullivan M, Rapp S, Fitzgibbon D, et al. Pain and the choice to
hasten death in patients with painful metastatic cancer. J Palliat
Care 1997;13:18-28.
17. Emanuel EJ, Fairclough DL, Daniels ER, et al. Euthanasia and
physician-assisted suicide: attitudes and experiences of oncology
patients, oncologists, and the public. Lancet 1996;347:1805-10.
18. Suarez-Almazor ME, Belzile M, Bruera E. Euthanasia and physi-
cian-assisted suicide: a comparative survey of physicians, termi-
nally ill cancer patients, and the general population. J Clin Oncol
1997;15:418-27.
19. Levy PS, Lemeshow LS. Sampling of populations: methods and
applications. 4th ed. New York (NY): John Wiley and Sons; 2009.
20. Emanuel EJ, Fairclough DL, Emanuel LL. Attitudes and desires
related to euthanasia and physician-assisted suicide among termi-
nally ill patients and their caregivers. JAMA 2000;284:2460-8.
21. Ganzini L, Nelson HD, Schmidt TA, et al. Physicians’ experiences
with the Oregon Death with Dignity Act. N Engl J Med 2000; 342:
557-63.
22. Legalize the right to die. Korea JoongAng Daily 2009; May 20.
Available: http://joongangdaily .joins.com /article /view .asp ?aid
=2905031 (ac cessed 2011 May 16).
23. Seale C, Addington-Hall J, McCarthy M. Awareness of dying:
prevalence, causes and consequences. Soc Sci Med 1997; 45: 477-84.
24. Addington-Hall JM, Karlsen S. A national survey of health pro-
fessionals and volunteers working in voluntary hospice services
in the UK. I. Attitudes to current issues affecting hospices and
palliative care. Palliat Med 2005;19:40-8.
25. Bachman JG, Alcser KH, Doukas DJ, et al. Attitudes of Michigan
physicians and the public toward legalizing physician-assisted sui-
cide and voluntary euthanasia. N Engl J Med 1996; 334:303-9.
26. Ganzini L, Johnston WS, McFarland BH, et al. Attitudes of
patients with amyotrophic lateral sclerosis and their care givers
toward assisted suicide. N Engl J Med 1998;339:967-73.
27. Field MJ, Cassel CK. Approaching death: improving care at the
end of life. Washington (DC): National Academy Press; 1997.
28. Jeong HS. Korea’s National Health Insurance — lessons from
the past three decades. Health Aff (Millwood) 2011;30:136-44.
Affiliations: From the Cancer Management Branch (Yun,
Han) and the Cancer Registration and Statistics Branch (S.
Park), Research Institute, National Cancer Center, Goyang,
Korea; the Department of Surgery (B.W. Park), Yonsei Uni-
versity Medical Center, Yonsei University College of Medi-
cine, Seoul, Korea; the Department of Obstetrics and Gyne-
cology (Cho), School of Medicine, Keimyung University,
Daegu, Korea; the Department of Surgery (S. Kim), Sam-
sung Medical Center, Sungkyunkwan University, School of
Medicine, Seoul, Korea; the Quality of Life Improvement
Team and Department of Oncology (D.H. Lee), University of
Ulsan College of Medicine, Asan Medical Center, Seoul,
Korea; the Section of Medical Oncology (S.N. Lee), Depart-
ment of Internal Medicine, Ewha Womans University School
of Medicine, Seoul, Korea; the Department of Surgery (E.S.
Lee), Anam Medical Center, Korea University, School of
Medicine, Seoul, Korea; the Department of Internal Medi-
cine (Kang), Postgraduate Medical School, Gyeongsang
National University, Jinju, Korea; the Departments of Med-
ical Oncology and Hematology (Si-Young Kim), Kyung Hee
University Hospital, Seoul, Korea; the Department of
Hemato-oncology (J.L. Lee), Fatima Hospital, Daegu, Korea;
the Division of Hemato-oncology (Heo), Department of
Internal Medicine, Seoul National University Hospital,
Seoul, Korea; the Department of Radiation Oncology (C.G.
Lee), Yonsei University College of Medicine, Yonsei Cancer
Center, Seoul, Korea; the Kwangju Christian Hospital (Lim),
Kwangju, Korea; the Division of Hemato-oncology (Sam
Yong Kim), Department of Internal Medicine, College of
Medicine Chungnam National University, Daejeon, Korea;
the Department of Hemato-oncology (Choi), Gangneung
Asan Hospital, Asan University School of Medicine, Gang -
neung, Korea; the Pohang Sunlin Hospital (Jeong), Pohang,
Korea; and the Department of Radiation Oncology (Chun),
Ajou University School of Medicine, Suwon, Korea
Contributors: Young Ho Yun and Kyung Hee Han con-
tributed substantially to the conception and design of the
study. Byeong Woo Park, Chi-Heum Cho, Sung Kim, Dae
Ho Lee, Soon Nam Lee, Eun Sook Lee, Jung Hun Kang, Si-
Young Kim, Jung Lim Lee, Dae Seog Heo, Chang Geol Lee,
Yeun Keun Lim, Sam Yong Kim, Jong Soo Choi, Hyun Sik
Jeong and Mison Chun contributed to data collection. Young
Ho Yun, Kyung Hee Han and Sohee Park analyzed and inter-
preted the data. All of the authors participated in the drafting
of the manuscript and its revision, and all gave their final
approval of the version submitted for publication.
Funding: This work was supported by the 2008 Korean
National Cancer Control Program by the Korean Ministry for
Health, Welfare and Family Affairs, and in part by a grant from
the Korean National Cancer Center (grant no. 0710730–3).
Acknowledgement:We thank Dr. Miriam Bloom (SciWrite
Biomedical Writing & Editing Services) for professional
editing.
CMAJ, July 12, 2011, 183(10) E679
